胶束电动力学毛细管色谱中有机调节剂对溶质容量因子的影响

将质量作用定律应用于胶束电动力学毛细管色谱中溶质、有机添加剂和胶束之间的相互作用研究,得到了溶质容是因子与各过程平衡常数及有机添加剂、表面活性剂浓度的关系的数学表达式。进一步分析表明,研究调节剂在胶束中可能有一定的溶解度,但这一过程对于胶束在电泳过程中的迁移速度几乎没有影响;有机添加剂对溶质容量因子的影响主要反映为其对表面活性剂临界胶束浓度的影响,在一级调节剂浓度不变的情况下,溶质容基因子与表面活性剂浓度之间满足很好的线性关系。     

L-天冬氨酸与阴离子表面活性剂SDS的相互作用

用电导法、表面张力法和荧光探针法测定了L-天冬氨酸(L-Asp)对十二烷基硫酸钠(SDS)胶束聚集性能的影响以及L-Asp在SDS胶束中的定位, 用循环伏安法研究了SDS/H₂O体系中L-Asp的电化学特性. 结果表明, L-Asp的加入能使SDS的临界胶束浓度cmc减小、胶束的聚集数增加. SDS表面胶束和SDS/n-C₄H₉OH/表面混合胶束均对L-Asp电化学氧化具有一定的催化作用.     

直链醇对反胶束体系中木素过氧化物酶催化活性的影响

根据研究发现, 在有醇作助表面活性剂的CTAB反胶束中木素过氧化物酶(LiP)不能表现活力, 而在水介质中CTAB对LiP的催化活性影响又不是很大. 为了揭示其中醇的影响, 本工作就不同碳链长度的醇对LiP酶催化性能的影响进行了研究. 由于CTAB反胶束体系中醇浓度较高, 且碳原子数大于4的直链醇在水中的溶解度又很小, 为此采用了LiP可在其中显示催化活性的CTAB正胶束、AOT反胶束和Brij30反胶束作介质, 通过研究这些介质中不同链长的醇对LiP催化活力的影响, 来探讨CTAB反胶束中木素过氧化物酶(LiP)不能表现活力的原因. 结果表明, 不管表面活性剂聚集体的结构、电性质及反胶束大小如何, 只要醇的浓度超过500 mmol•L^－1 (丁醇≥1200 mmol•L^－1), LiP在上述原本可显示活力的介质中均无催化活性. 据此推测CTAB反胶束中木素过氧化物酶(LiP)不能表现活力的原因主要是由助表面活性剂醇造成的.     

多种类表面活性剂临界胶束浓度定量构效关系

表面活性剂的临界胶束浓度(CMC)是个非常重要的物质特性参数, CMC在研究表面活性剂的工业应用和生物利用方面发挥着关键作用. 本工作提出了一个新的拓扑指数—扩展距离矩阵, 建立了一个稳定的构效关系模型, 并对175种表面活性剂的临界胶束浓度进行了计算预测. 结果表明, 基于新的拓扑指数建立的构效关系模型计算临界胶束浓度能给出稳定可靠的预测结果, 其预测结果相关性系数R²(training set)=0.9295, 相对标准偏差ARD(training set)=8.20%, R²(testing set)=0.9257, ARD(testing set)=6.76%. 与文献中模型预测结果的对比表明, 本工作在稳定性和可靠性上均有显著改善.     

苄泽类非离子表面活性剂与离子型表面活性剂复配性质研究

通过测定苄泽类非离子型表面活性剂Brij58、Brij76、Brij78与阳离子表面活性剂十六烷基三甲基溴化铵(CTAB)、阴离子表面活性剂十二烷基硫酸钠(SDS)复配体系的表面张力,研究了复配体系的形成胶束能力、降低表面张力效率、降低表面张力能力3种增效作用,并结合复配体系中表面活性剂分子间的相互作用参数进行了深入的讨论。研究结果表明,与阳离子表面活性剂复配时,Brij76/CTAB体系增效作用最强;与阴离子表面活性剂复配时,Brij58/SDS复配体系增效作用最强,而且苄泽类非离子型表面活性剂与阴离子表面活性剂复配增效作用更加显著。     

苄泽类非离子型表面活性剂与明胶的相互作用

采用表面张力和稳态荧光光谱法考察了具有不同疏水结构的2种苄泽类非离子型表面活性剂Brij58和Brij78与明胶之间的相互作用。结果表明,苄泽类非离子型表面活性剂与明胶之间相互作用的驱动力为疏水作用力,且两者之间的相互作用受到其疏水基团的影响,Brij78在明胶溶液中的临界聚集浓度低于Brij58体系,表明疏水链更长的Brij78与明胶之间的相互作用更强。明胶分子的内源荧光光谱强度受苄泽类非离子型表面活性剂的影响,但最大吸收峰位置未发生蓝移,Brij78/明胶体系的内源荧光强度高于Brij58/明胶体系;此外,表面活性剂浓度较低时,明胶的加入使溶液中疏水微区极性明显降低,且明胶浓度越大降低程度越大。     

有机磷化合物高效液相色谱保留和手性识别机理的研究

在正相条件下,对一系列手性磷有机化合物进行了高效液相色谱拆分,探索运用定量结构-对映异构体选择性保留关系的方法,将对映异构体的色谱保留和溶质分子描述参数相关性联系建立定量方程,研究了色谱保留和手性识别机理,结果表明:在Sumichiral OA4700手性固定相上,对硫代磷酰胺酯类化合物色谱保留贡献最大的是其LUMO参数,即相应的氢键和(或)π-π相互作用;手性识别与logP和LUMO相应的作用力相关.     

十二烷基硫酸钠水溶液的动态表面吸附性质

利用MPTC型气泡压力张仪研究了十二烷基硫酸钠(SDS)溶液在不同NaCl 浓度下的动态表面吸附性质, 分析了离子型表面活性剂在表面吸附层和胶束中形成双电层结构产生表面电荷对动态表面扩散过程和胶束性质的影响. 结果表明, SDS在表面吸附过程中, 表面电荷的存在会产生5.5 kJ·mol^-1的吸附势垒(E_a), 显著降低十二烷基硫酸根离子(DS^-)的有效扩散系数(D_eff). 十二烷基硫酸根离子的有效扩散系数与自扩散系数(D)的比值(D_eff/D)仅为0.013, 这表明SDS与非离子型表面活性剂不同, 在吸附初期为混合动力控制吸附机制. 加入NaCl可以降低吸附势垒. 当加入不小于80 mmol·L^-1 NaCl后, E_a小于0.3 kJ·mol^-1, D_eff/D在0.8-1.2之间, 表现出与非离子型表面活性剂相同的扩散控制吸附机制. 同时, 通过分析SDS胶束溶液的动态表面张力获得了表征胶束解体速度的常数(k₂). 发现随着NaCl 浓度的增大, k₂减小, 表明SDS胶束表面电荷的存在会增加十二烷基硫酸根离子间的排斥力, 促进胶束解体.     

Brij类表面活性剂与Laponite纳米颗粒的相互作用及其稳定乳液的研究

通过表面张力、Zeta电位和流变学参数的测定, 研究了聚氧乙烯烷基醚类非离子型表面活性剂(Brij 30和Brij 35)在合成锂皂石(Laponite)纳米颗粒表面的吸附及对Laponite水分散体系中颗粒间相互作用和体系粘度的影响. 结果表明, 这类表面活性剂能显著地吸附在Laponite颗粒表面上, 且吸附量随其分子中POE链长短而不同. 这种吸附没有改变Laponite粒子的带电性质, 但一定程度地降低了Laponite颗粒Zeta电位; 吸附也会减弱颗粒间的相互作用, 降低体系的粘度. 实验以Laponite和Brij为乳化剂, 制备了O/W型乳状液. 乳液稳定性变化和乳液粒径分布结果表明, 体系中Brij的浓度较低时, 乳液的性质主要是由Laponite颗粒决定的; 而Brij浓度较高时, 则主要取决于Brij表面活性剂. 高速剪切含Brij的Laponite水分散体系, 剪切后表面张力随时间的变化表明, 剪切作用会使得吸附在Laponite颗粒表面的Brij分子不同程度地解吸下来. 这也意味着乳液制备时, 高速剪切作用也会造成Brij分子自Laponite颗粒表面的脱附, 这可能是非离子表面活性剂与阳离子表面活性剂对负电固体颗粒稳定乳液影响不同的原因.     

Gemini表面活性剂(12-6-12)和DNA的相互作用

应用紫外光谱、荧光探针、zeta 电位、动态光散射和凝胶电泳等方法探讨了阳离子gemini 表面活性剂C₁₂H₂₅N⁺(CH₃)₂―(CH₂)₆―(CH₃)₂N⁺C₁₂H₂₅·2Br^-(12-6-12)与DNA之间的相互作用. 研究结果表明, 与传统表面活性剂相比, 偶联表面活性剂特殊的分子结构使其与DNA的作用更强烈. DNA引导表面活性剂在其链周围形成类胶束结构, 开始形成类胶束时对应的表面活性剂临界聚集浓度(CAC)比纯表面活性剂临界胶束浓度(CMC)低两个数量级. CAC与DNA的浓度无关, 而与表面活性剂之间的疏水作用以及表面活性剂与DNA之间的静电吸引作用密切相关. Zeta 电位和凝胶电泳结果显示了DNA链所带负电荷逐渐被阳离子表面活性剂中和的过程. 借助原子力显微镜(AFM)成功观察到了松散的线团状DNA, 球状体随机地分散在DNA链上形成类似于串珠的结构、尺寸较大的球形复合物以及其由于吸附多余的表面活性剂重新带正电而被溶解得到的较小DNA/12-6-12聚集体. 圆二色(CD)光谱结果显示, 12-6-12可以诱导DNA的构象发生改变.     

Micellar Liquid Chromatography Study of Quantitative Retention–Activity Relationships for Antihypertensive Drugs

Use of micellar mobile phases in reversed-phase liquid chromatography (RPLC) results in hydrophobic and electrostatic sites for interaction. Modified stationary phases in micellar liquid chromatography (MLC) are structurally similar to biomembranes. To confirm this we focused on the effects of the type and concentration of surfactant (Brij 35, SDS, and CTAB) and mobile phase pH on the retention of antihypertensive drugs on modified C₁₈ stationary phases. Quantitative retention-activity relationships are proposed for the drugs and the different surfactants and compared with those obtained using aqueous–organic mobile phases. Finally, a correlation was obtained between the logarithm of retention factors (log k) and the toxicity (LD₅₀) of antihypertensive drugs. Revised: 14 September 2005 and 4 April 2006     

Separation and mechanism elucidation for six structure-like matrine-type alkaloids by micellar liquid chromatography

A mixed micellar liquid chromatography (MLC) method, the mobile phase consisting of anionic surfactant SDS and nonionic surfactant Brij35, was firstly developed for the separation and determination of six structure-like matrine-type alkaloids, including matrine, oxymatrine, sophocarpine, oxysophocarpine, sophoridine, and oxysophoridine. The factors influencing the resolution of the six alkaloids were systematically investigated and optimized, including the micellar composition and concentration, column temperature, the type and amount of organic solvent, and the pH values in the mobile phases. Under the optimized separation conditions, the six matrine-type alkaloids could be easily isocratically eluted with a baseline separation within 22 min. Under the designated conditions (SDS concentration from 10 to 50 mM, Brij35 from 5 to 30 mM, pH 3 and 5% 1-propanol), the hydrophobic selectivity was negatively correlated with the concentration of Brij35 but not with SDS. The functional group selectivity of the carbonyl group, double bond, and diastereomers, all decreased with the increase in percentage of SDS in the mixed micellar phase, because the strong electrostatic force masks other molecular forces which can discriminate the retention of the analytes. Therefore, such a combination in surfactants of MLC is a powerful strategy to increase the selectivity by adjusting the balance among the various molecular interaction forces influencing analytes' retention. Finally, the developed method was successfully used to separate and determine the contents of main alkaloids in Sophora medicinal plants, S. flavescens Ait. In summary, the mixed MLC is a valuable approach to separate and determine the structure-like multi-component natural samples.     

Micellar liquid chromatography with dodecyl dimethyl betaine as an in vitro method for prediction of protein-drug binding

With the accelerating development of new drugs, there is a high need for rapid and simple screening technologies. In this paper, a new in vitro method, dodecyl dimethyl betaine (BS-12) micellar liquid chromatography (MLC) was presented for prediction of protein-drug binding based on the similar property of BS-12 micelles to protein. The predictive possibility of this method was validated by comparing the retention factors of drugs (antidiabetic and antibacterial drugs) on C18 modified by different surfactants with those on the protein column. Through the investigation of the concentration and pH effect on the retention of the drugs in BS-12 MLC, quantitative retention-protein binding relationships were established according to the retention factors in 0.2 M BS-12 (pH 7.4) MLC and those on the protein column. According to the relationships established, the protein binding of seven drugs for psychiatric disorders, six potential drugs for antibiotics and four commercial antibiotics were predicted. The results were consistent with those on the BSA column very well. This indicated, BS-12 MLC was a simple, fast and reproducible method to predict protein-drug binding.     

Micellar liquid chromatography: suitable technique for screening analysis

The screening capability of micellar liquid chromatography (MLC) is discussed using the reported chromatographic data of several sets of compounds (amino acids, beta-blockers, diuretics, phenethylamines, phenols, polynuclear aromatic hydrocarbons, steroids and sulfonamides) and new results (sulfonamides and steroids). The chromatographic data are treated with an interpretive optimisation resolution procedure to obtain the best separation conditions. Usually, the pH and the concentration of surfactant (sodium dodecyl sulfate, SDS, or cetyltrimethylammonium bromide) for the optimal mobile phase were 2.5-3 and < 0.12 M, respectively. The nature and concentration of organic solvent depended on the polarity of the eluted compounds: a low volume fraction of propanol (approximately 1%, v/v) was useful to separate the amino acids, with log P(o/w) < -1 (where P(o/w) is the octanol-water partition coefficient). A greater concentration of this solvent (approximately 5-7%) was needed for compounds in the range -1 < log P(o/w) < 2, as with the studied diuretics and sulfonamides, and a high concentration of propanol (approximately 15%) or a low concentration of butanol (< 10%) had to be used for less polar compounds with 1 < log P(o/w) < 3, such as the beta-blockers. Pentanol (< 6%) was more suitable for the even less polar compounds with log P(o/w) > 3, such as the steroids. For basic drugs such as the phenethylamines (0 < log P(o/w) < 1.7), eluted with a micellar eluent of anionic SDS, propanol was too weak. A study is also shown for mixtures of sulfonamides (log P(o/w) = -1.2 to 1.7) and steroids (log P(o/w) = 3.0-8.1) eluted from conventional C18 columns with SDS mobile phases containing acetonitrile and 1-pentanol, respectively, which are compared with classical acetonitrile-water and methanol-water mixtures. The results complement a previous study on beta-blockers (log P(o/w) = -0.03 to 2.8) and reveal that MLC is a very competitive technique for the screening of compounds against conventional RPLC, due to its peculiar behaviour with regard to the selectivity and elution strength. The concentration of organic solvent needed to obtain sufficiently low retention times (even for highly hydrophobic steroids with log P(o/w) = 7-8) is also appreciably smaller for MLC, which reduces the environmental impact of the mobile phases.     

Isocratic and gradient elution in micellar liquid chromatography with Brij‐35

Polyoxyethylene(23)lauryl ether (known as Brij‐35) is a nonionic surfactant, which has been considered as an alternative to the extensively used in micellar liquid chromatography anionic surfactant sodium lauryl (dodecyl) sulfate, for the analysis of drugs and other types of compounds. Brij‐35 is the most suitable nonionic surfactant for micellar liquid chromatography, owing to its commercial availability, low cost, low toxicity, high cloud temperature, and low background absorbance. However, it has had minor use. In this work, we gather and discuss some results obtained in our laboratory with several β‐blockers, sulfonamides, and flavonoids, concerning the use of Brij‐35 as mobile phase modifier in the isocratic and gradient modes. The chromatographic performance for purely micellar eluents (with only surfactant) and hybrid eluents (with surfactant and acetonitrile) is compared. Brij‐35 increases the polarity of the alkyl‐bonded stationary phase and its polyoxyethylene chain with the hydroxyl end group allows hydrogen‐bond interactions, especially for phenolic compounds. This offers the possibility of using aqueous solutions of Brij‐35 as mobile phases with sufficiently short retention times. The use of gradients of acetonitrile to keep the concentration of Brij‐35 constant is another interesting strategy that yields a significant reduction in the peak widths, which guarantee high resolution.     

Quantitative structure-retention relationships for ionic and non-ionic compounds in biopartitioning micellar chromatography

Quantitative structure-retention relationships, QSRRs, represent a powerful tool in chromatography. The objectives of QSRR studies are to predict the chromatographic retention behaviour of solutes based on their structural properties, to elucidate retention mechanisms, to optimize the separation of complex mixtures or to prepare experimental designs. In this paper, using the retention factors of 151 structurally unrelated solutes that cover a wide range of hydrophobicity, molecular size, hydrogen bonding properties and ionization degrees obtained in biopartitioning micellar chromatography (BMC) at different Brij35 micellar concentrations, several multivariate QSRR models are tested. It is demonstrated that the chromatographic retention of any molecule in BMC, independently of its family, can be adequately described by its hydrophobicity (expressed as log P) and its anionic and cationic total molar charge (expressed as alpha(A) and alpha(B)).     

Development of predictive retention-activity models of butyrophenones by biopartitioning micellar chromatography

The predictive and interpretative capability of quantitative chromatographic retention-biological activity models is supported by the fact that in adequate experimental conditions the solute partitioning into the chromatographic system can emulate the solute partitioning into lipid bilayers of biological membranes, which is the basis of drug and metabolite uptake, passive transport across membranes and bioaccumulation. The use of retention data obtained in biopartitioning micellar chromatography (BMC) has been demonstrated to be helpful in describing the biological behaviour of different kinds of drugs. In this chromatographic system, polioxyethylene 23 lauryl ether Brij35 micellar mobile phases and C(18) reversed stationary phase in adequate experimental conditions are used. The RP-HPLC capacity factors of butyrophenones were determined using different Brij35 concentrations as micellar mobile phases. Relationships between seven biological activities of butyrophenones reported in bibliography and retention data were established and their predictive and interpretative ability evaluated. These relationships were significant between preclinical pharmacology and therapeutic efficacy parameters and the retention factors of butyrophenones (0.89 < R(2) < 0.98). The results indicate that the retention of compounds in BMC is capable of describing and predicting in vitro the biological activities of butyrophenones. This approach can be very useful in the development of new neuroleptic drugs, avoiding the use of experimental animals.